The Application of Hyaluronic Acid in Drug Delivery
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Materials Chemistry".
Deadline for manuscript submissions: closed (28 February 2023) | Viewed by 19867
Special Issue Editors
Interests: liposomes; actively targeted drug delivery systems; hyaluronic acid; anticancer drugs
Special Issues, Collections and Topics in MDPI journals
Interests: polymer and lipid nanoparticles; liposomes; bioconjugates; drug delivery; controlled drug release; active targeting
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Hyaluronic acid (HA) is a very attractive molecule for use either as a targeting moiety or for the delivery of active compounds. The application of HA in active targeting is due to its ability to reach the CD44 receptor, which is overexpressed in many tumors and on cancer stems cells. Exploiting this ligand-receptor interaction, the use of HA to actively target nanosystems is now a rapidly-growing platform for targeting CD44-overexpressing cells, to reach more specific therapies and/or diagnostics. Moreover, it is also widely used for parenteral systems in the case of sustained release formulations by preparing particles and hydrogels.
The aim of this Special Issue is to discuss the design, preparation, characterization and biomedical applications of drug delivery systems based on the use of HA. We cordially invite you to contribute to this themed issue. Both original research papers and comprehensive review articles are highly welcome.
Prof. Dr. Silvia Arpicco
Dr. Barbara Stella
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Hyaluronic acid
- Drug delivery
- Nanosystems
- Active drug targeting
- CD44 receptor
- Imaging
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.